In a very thoughtful News and Views article (Mayosi, B. M. MOGE(S): a standardized classification of cardiomyopathies? Nat. Rev. Cardiol. 11, 134–135 [2014]),1 Professor Mayosi described MOGE(S) as an “admirable achievement on the path towards a globally accepted nomenclature for cardiomyopathy”.2 He appropriately emphasized the lack of examples of aetiological notation for important cardiomyopathies from low-income and middle-income countries, such as tropical endomyocardial fibrosis (EMF; also known as tropical endomyocardial disease, constrictive endocarditis, and endocarditis parietalis fibroplastica), which is one of the most prevalent causes of restrictive cardiomyopathy.3 Mayosi suggests that an aetiological category for unexplained (or idiopathic) cardiomyopathy would improve the clinical utility of the MOGE(s) scheme.1 The authors of the scheme completely agree, and reiterate that the classification system (or nosology) is flexible, conveniently expandable, and allows easy modification of the MOGE(S) online app.4 The first update to the app has been already proposed to improve the description of arrhythmogenic right ventricular cardiomyopathy.5

MOGE(S) nosology in low-to-middle-income countries.

ARBUSTINI, ELOISA;BELLAZZI, RICCARDO;
2014-01-01

Abstract

In a very thoughtful News and Views article (Mayosi, B. M. MOGE(S): a standardized classification of cardiomyopathies? Nat. Rev. Cardiol. 11, 134–135 [2014]),1 Professor Mayosi described MOGE(S) as an “admirable achievement on the path towards a globally accepted nomenclature for cardiomyopathy”.2 He appropriately emphasized the lack of examples of aetiological notation for important cardiomyopathies from low-income and middle-income countries, such as tropical endomyocardial fibrosis (EMF; also known as tropical endomyocardial disease, constrictive endocarditis, and endocarditis parietalis fibroplastica), which is one of the most prevalent causes of restrictive cardiomyopathy.3 Mayosi suggests that an aetiological category for unexplained (or idiopathic) cardiomyopathy would improve the clinical utility of the MOGE(s) scheme.1 The authors of the scheme completely agree, and reiterate that the classification system (or nosology) is flexible, conveniently expandable, and allows easy modification of the MOGE(S) online app.4 The first update to the app has been already proposed to improve the description of arrhythmogenic right ventricular cardiomyopathy.5
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1027585
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact